Hepatocellular carcinoma prevalence and mortality in a male state prison population

Jacques Baillargeon, Ned Snyder, Roger D. Soloway, David Paar, Gwen Baillargeon, Anne C. Spaulding, Brad H. Pollock, Christine M. Arcari, Brie A. Williams, Benny Raimer

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Objectives. The incidence of hepatocellular carcinoma (HCC) in the United States has increased dramatically over the last two decades, largely because of an increase in the number of people with advanced hepatitis C virus (HCV) infection. U.S. prisoners are at high risk for HCC, given their elevated rates of HCV infection, comorbid hepatitis B virus (HBV) infection, and alcoholic liver disease. The purpose of our study was to examine the prevalence and mortality of HCC in the nation's largest state prison system. Methods. The study population consisted of 325,477 male Texas Department of Criminal Justice (TDCJ) inmates who were incarcerated between January 1, 2003, and July 31, 2006. Information on medical conditions and demographic characteristics was obtained from an institution-wide medical information system. Results. During the 3.5-year study period, 176 male TDCJ inmates (54 per 100,000) were diagnosed with HCC and 108 (33 per 100,000) died as a result of HCC. Inmates who were Hispanic, older, and infected with HCV, HBV, or human immunodeficiency virus had elevated rates of both HCC prevalence and mortality. After adjusting for all study covariates, HCC prevalence, but not mortality, was modestly elevated among inmates with diabetes. Conclusions. Our study showed that the Texas male prison population had a sevenfold higher prevalence of HCC than the general U.S. male population and a fourfold higher death rate from HCC. These findings likely reflect the high concentration of HCC-related risk factors, particularly HCV, among prisoners.

Original languageEnglish (US)
Pages (from-to)120-126
Number of pages7
JournalPublic Health Reports
Volume124
Issue number1
StatePublished - Jan 2009

Fingerprint

Prisons
Hepatocellular Carcinoma
Mortality
Population
Hepacivirus
Virus Diseases
Criminal Law
Prisoners
Hepatitis B virus
Alcoholic Liver Diseases
Hispanic Americans
Information Systems
Demography
HIV

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Baillargeon, J., Snyder, N., Soloway, R. D., Paar, D., Baillargeon, G., Spaulding, A. C., ... Raimer, B. (2009). Hepatocellular carcinoma prevalence and mortality in a male state prison population. Public Health Reports, 124(1), 120-126.

Hepatocellular carcinoma prevalence and mortality in a male state prison population. / Baillargeon, Jacques; Snyder, Ned; Soloway, Roger D.; Paar, David; Baillargeon, Gwen; Spaulding, Anne C.; Pollock, Brad H.; Arcari, Christine M.; Williams, Brie A.; Raimer, Benny.

In: Public Health Reports, Vol. 124, No. 1, 01.2009, p. 120-126.

Research output: Contribution to journalArticle

Baillargeon, J, Snyder, N, Soloway, RD, Paar, D, Baillargeon, G, Spaulding, AC, Pollock, BH, Arcari, CM, Williams, BA & Raimer, B 2009, 'Hepatocellular carcinoma prevalence and mortality in a male state prison population', Public Health Reports, vol. 124, no. 1, pp. 120-126.
Baillargeon J, Snyder N, Soloway RD, Paar D, Baillargeon G, Spaulding AC et al. Hepatocellular carcinoma prevalence and mortality in a male state prison population. Public Health Reports. 2009 Jan;124(1):120-126.
Baillargeon, Jacques ; Snyder, Ned ; Soloway, Roger D. ; Paar, David ; Baillargeon, Gwen ; Spaulding, Anne C. ; Pollock, Brad H. ; Arcari, Christine M. ; Williams, Brie A. ; Raimer, Benny. / Hepatocellular carcinoma prevalence and mortality in a male state prison population. In: Public Health Reports. 2009 ; Vol. 124, No. 1. pp. 120-126.
@article{3445d2521014411ca47266074ca64695,
title = "Hepatocellular carcinoma prevalence and mortality in a male state prison population",
abstract = "Objectives. The incidence of hepatocellular carcinoma (HCC) in the United States has increased dramatically over the last two decades, largely because of an increase in the number of people with advanced hepatitis C virus (HCV) infection. U.S. prisoners are at high risk for HCC, given their elevated rates of HCV infection, comorbid hepatitis B virus (HBV) infection, and alcoholic liver disease. The purpose of our study was to examine the prevalence and mortality of HCC in the nation's largest state prison system. Methods. The study population consisted of 325,477 male Texas Department of Criminal Justice (TDCJ) inmates who were incarcerated between January 1, 2003, and July 31, 2006. Information on medical conditions and demographic characteristics was obtained from an institution-wide medical information system. Results. During the 3.5-year study period, 176 male TDCJ inmates (54 per 100,000) were diagnosed with HCC and 108 (33 per 100,000) died as a result of HCC. Inmates who were Hispanic, older, and infected with HCV, HBV, or human immunodeficiency virus had elevated rates of both HCC prevalence and mortality. After adjusting for all study covariates, HCC prevalence, but not mortality, was modestly elevated among inmates with diabetes. Conclusions. Our study showed that the Texas male prison population had a sevenfold higher prevalence of HCC than the general U.S. male population and a fourfold higher death rate from HCC. These findings likely reflect the high concentration of HCC-related risk factors, particularly HCV, among prisoners.",
author = "Jacques Baillargeon and Ned Snyder and Soloway, {Roger D.} and David Paar and Gwen Baillargeon and Spaulding, {Anne C.} and Pollock, {Brad H.} and Arcari, {Christine M.} and Williams, {Brie A.} and Benny Raimer",
year = "2009",
month = "1",
language = "English (US)",
volume = "124",
pages = "120--126",
journal = "Public Health Reports",
issn = "0033-3539",
publisher = "Association of Schools of Public Health",
number = "1",

}

TY - JOUR

T1 - Hepatocellular carcinoma prevalence and mortality in a male state prison population

AU - Baillargeon, Jacques

AU - Snyder, Ned

AU - Soloway, Roger D.

AU - Paar, David

AU - Baillargeon, Gwen

AU - Spaulding, Anne C.

AU - Pollock, Brad H.

AU - Arcari, Christine M.

AU - Williams, Brie A.

AU - Raimer, Benny

PY - 2009/1

Y1 - 2009/1

N2 - Objectives. The incidence of hepatocellular carcinoma (HCC) in the United States has increased dramatically over the last two decades, largely because of an increase in the number of people with advanced hepatitis C virus (HCV) infection. U.S. prisoners are at high risk for HCC, given their elevated rates of HCV infection, comorbid hepatitis B virus (HBV) infection, and alcoholic liver disease. The purpose of our study was to examine the prevalence and mortality of HCC in the nation's largest state prison system. Methods. The study population consisted of 325,477 male Texas Department of Criminal Justice (TDCJ) inmates who were incarcerated between January 1, 2003, and July 31, 2006. Information on medical conditions and demographic characteristics was obtained from an institution-wide medical information system. Results. During the 3.5-year study period, 176 male TDCJ inmates (54 per 100,000) were diagnosed with HCC and 108 (33 per 100,000) died as a result of HCC. Inmates who were Hispanic, older, and infected with HCV, HBV, or human immunodeficiency virus had elevated rates of both HCC prevalence and mortality. After adjusting for all study covariates, HCC prevalence, but not mortality, was modestly elevated among inmates with diabetes. Conclusions. Our study showed that the Texas male prison population had a sevenfold higher prevalence of HCC than the general U.S. male population and a fourfold higher death rate from HCC. These findings likely reflect the high concentration of HCC-related risk factors, particularly HCV, among prisoners.

AB - Objectives. The incidence of hepatocellular carcinoma (HCC) in the United States has increased dramatically over the last two decades, largely because of an increase in the number of people with advanced hepatitis C virus (HCV) infection. U.S. prisoners are at high risk for HCC, given their elevated rates of HCV infection, comorbid hepatitis B virus (HBV) infection, and alcoholic liver disease. The purpose of our study was to examine the prevalence and mortality of HCC in the nation's largest state prison system. Methods. The study population consisted of 325,477 male Texas Department of Criminal Justice (TDCJ) inmates who were incarcerated between January 1, 2003, and July 31, 2006. Information on medical conditions and demographic characteristics was obtained from an institution-wide medical information system. Results. During the 3.5-year study period, 176 male TDCJ inmates (54 per 100,000) were diagnosed with HCC and 108 (33 per 100,000) died as a result of HCC. Inmates who were Hispanic, older, and infected with HCV, HBV, or human immunodeficiency virus had elevated rates of both HCC prevalence and mortality. After adjusting for all study covariates, HCC prevalence, but not mortality, was modestly elevated among inmates with diabetes. Conclusions. Our study showed that the Texas male prison population had a sevenfold higher prevalence of HCC than the general U.S. male population and a fourfold higher death rate from HCC. These findings likely reflect the high concentration of HCC-related risk factors, particularly HCV, among prisoners.

UR - http://www.scopus.com/inward/record.url?scp=66949124798&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66949124798&partnerID=8YFLogxK

M3 - Article

C2 - 19413034

AN - SCOPUS:66949124798

VL - 124

SP - 120

EP - 126

JO - Public Health Reports

JF - Public Health Reports

SN - 0033-3539

IS - 1

ER -